Diagnosis: Which tools should be used when?
Episode 1. “Selecting the right guideline for the right patient is the art of bladder cancer management,” says Ashish Kamat. But what does that look like in practice – especially when diagnostic tools, cystoscopy techniques, and biomarker use vary across regions? In this episode, Kamat and Morgan Rouprêt explore how NMIBC diagnosis and staging unfold in real-world clinical settings. View transcript.
Chapters
00:00 Welcome and introductions
00:32 Choosing the right diagnostic tools
02:47 Cystoscopy techniques and tips
05:10 Cytology and biomarkers in NMIBC
08:24 Imaging as an adjunct for staging
11:46 Regional practice vs clinical guidelines
15:24 Summary and wrap-up
Read more about NMIBC diagnostic tools.
Meet the guest speaker
Morgan Rouprêt, MD, PhD
Morgan Rouprêt is a Professor of Urology at AP-HP Sorbonne University and Pitié-Salpêtrière Hospital, Paris, France. He serves as Chair of the European Section of Onco-Urology (ESOU) and is Editor-in-Chief of European Urology Oncology.
Disclosures: Consulting and speaker engagements with Astellas, AstraZeneca, CG Oncology, Ferring, Intuitive Surgical, Janssen, MSD, Pfizer, and Roche.